Stem Cell- and Cell-Based Therapies for Ischemic Stroke
Stroke is the second cause of disability worldwide as it is expected to increase its incidence and prevalence. Despite efforts to increase the number of patients eligible for recanalization therapies, a significant proportion of stroke survivors remain permanently disabled. This outcome boosted the...
Main Authors: | Delia Carmen Nistor-Cseppentö, Maria Carolina Jurcău, Anamaria Jurcău, Felicia Liana Andronie-Cioară, Florin Marcu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/9/11/717 |
Similar Items
-
Dental Mesenchymal Stem Cell Secretome: An Intriguing Approach for Neuroprotection and Neuroregeneration
by: Agnese Gugliandolo, et al.
Published: (2021-12-01) -
The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives
by: Maria Carolina Jurcău, et al.
Published: (2022-10-01) -
Modulatory effects of mesenchymal stem cells on microglia in ischemic stroke
by: Lei Hao, et al.
Published: (2023-01-01) -
Extracellular vesicles derived from different sources of mesenchymal stem cells: therapeutic effects and translational potential
by: Jiaxin Cai, et al.
Published: (2020-05-01) -
Neural stem/progenitor cell‐derived extracellular vesicles: A novel therapy for neurological diseases and beyond
by: Xiangyu Li, et al.
Published: (2023-02-01)